RLYB - Rallybio - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

14.6M

Cash

137.8M

Avg Qtr Burn

-15.54M

Short % of Float

6.50%

Insider Ownership

5.61%

Institutional Own.

86.70%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
RLYB212 Details Fetal and Neonatal Alloimmune Thrombocytopenia	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RLYB116 Details Fetal and Neonatal Alloimmune Thrombocytopenia	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RLYB211 Details Fetal and Neonatal Alloimmune Thrombocytopenia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.